Commonwealth Equity Services, LLC Aspira Women'S Health Inc. Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$3.19 - $5.48 $89,320 - $153,440	-28,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$3.0 - $6.71 $300,000 - $671,000	-100,000 Reduced 78.13%	28,000 $187,000
Q3 2020 Nov 05, 2020	SELL	$2.54 - $4.56 $2,540 - $4,560	-1,000 Reduced 0.78%	128,000 $394,000
Q2 2020 Aug 12, 2020	BUY	$0.78 - $5.25 $100,620 - $677,250	129,000 New	129,000 $495,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.